ArticleJournal of speech, language, and hearing research : JSLHR2026
A Combined Speech-Language and Counseling Intervention for Primary Progressive Aphasia: Acceptability, Feasibility, and Preliminary Outcomes.
Article in Journal of speech, language, and hearing research : JSLHR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Combined Speech-Language and Counseling Intervention for Primary Progressive Aphasia: Acceptability, Feasibility, and Preliminary Outcomes.Journal of speech, language, and hearing research : JSLHR · 2026Article
- "Doing the Best I Can": Qualitative Outcomes and Participant Feedback From a Combined Communication and Counselling Treatment for Primary Progressive Aphasia.International journal of language & communication disordersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeIndividuals with primary progressive aphasia (PPA) face negative psychosocial repercussions, yet few studies have investigated counseling for this population. In a prior study, a novel intervention encompassing script training and aphasia-modified cognitive behavioral therapy was piloted with an individual with PPA, yielding promising results. The purpose of this study is to determine the acceptability and feasibility of this intervention for individuals with different PPA subtypes, with secondary aims of understanding preliminary treatment outcomes and evaluating the sensitivity of selected psychosocial measures.
methodNine participants with PPA were recruited (three with nonfluent/agrammatic variant, three with logopenic variant, and three with semantic variant). Acceptability was measured using a posttreatment questionnaire. Feasibility was examined via intervention adherence, independent practice engagement, retention, assessment completion, interrater reliability, and fidelity ratings. Speech-language outcomes were evaluated via hypothesis testing using simulation analysis from pre- to posttreatment for all participants and from pretreatment to follow-up time points for six participants. Counseling outcomes at posttreatment were measured via psychosocial scales and analyzed using Wilcoxon signed-ranks tests.
resultsFindings indicate that this treatment is acceptable and feasible. All participants demonstrated significant improvement in speech-language performance following treatment, with five participants demonstrating significant improvement up to 1 year posttreatment. Despite promising qualitative evidence regarding counseling outcomes, a sensitive quantitative measure of psychosocial functioning was not identified.
conclusionsPairing tailored speech-language interventions with counseling for individuals with heterogeneous PPA phenotypes is acceptable and feasible. Preliminary outcomes indicate positive communication findings and that alternative psychosocial measures may be beneficial in a future efficacy trial. SUPPLEMENTAL MATERIAL: https://doi.org/10.23641/asha.31836103.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.